Abstract
Over the last few years, samples from the marine environment have been screened for a variety of compounds with different biological activities. Among all marine organisms, sponges represent one of the most promising sources of leads in the research of new cancer drugs. However, there are few reports on screening Brazilian marine sponges for biological activities. In the following review, the current status of natural product research relating to Brazilian marine sponges is summarized, particularly for compounds demonstrating potential antitumor activity.
Keywords: Brazilian marine sponges, cancer, natural products, marine environment, cancer drugs, screening Brazilian, drug leads, sterols, Brazilian coastline, ovarian cancer cell line
Current Pharmaceutical Biotechnology
Title: Current Status on Natural Products with Antitumor Activity from Brazilian Marine Sponges
Volume: 13 Issue: 1
Author(s): Mario Luiz Conte da Frota Junior, Renata Biegelmeyer da Silva, Beatriz Mothes, Amelia Teresinha Henriques and Jose Claudio Fonseca Moreira
Affiliation:
Keywords: Brazilian marine sponges, cancer, natural products, marine environment, cancer drugs, screening Brazilian, drug leads, sterols, Brazilian coastline, ovarian cancer cell line
Abstract: Over the last few years, samples from the marine environment have been screened for a variety of compounds with different biological activities. Among all marine organisms, sponges represent one of the most promising sources of leads in the research of new cancer drugs. However, there are few reports on screening Brazilian marine sponges for biological activities. In the following review, the current status of natural product research relating to Brazilian marine sponges is summarized, particularly for compounds demonstrating potential antitumor activity.
Export Options
About this article
Cite this article as:
Luiz Conte da Frota Junior Mario, Biegelmeyer da Silva Renata, Mothes Beatriz, Teresinha Henriques Amelia and Claudio Fonseca Moreira Jose, Current Status on Natural Products with Antitumor Activity from Brazilian Marine Sponges, Current Pharmaceutical Biotechnology 2012; 13 (1) . https://dx.doi.org/10.2174/138920112798868674
DOI https://dx.doi.org/10.2174/138920112798868674 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
Current Pharmaceutical Biotechnology Biological Activities of Eco-Friendly Synthesized Hantzsch Adducts
Medicinal Chemistry Technologies for Translational Imaging Using Generators in Oncology
Recent Patents on Anti-Cancer Drug Discovery Personalized Medicine for Glioblastoma: Current Challenges and Future Opportunities
Current Molecular Medicine Novel Antitumor Strategies Using Cytokine PEDF for Prostate Cancer Therapy
Current Angiogenesis (Discontinued) The Bax Inhibitor-1 (BI-1) Family in Apoptosis and Tumorigenesis
Current Molecular Medicine The Immune System in Cancer Prevention, Development and Therapy
Anti-Cancer Agents in Medicinal Chemistry Dasatinib: An Anti-Tumour Agent via Src Inhibition
Current Drug Targets Design, Preparation and Characterization of Modular Squalene-based Nanosystems for Controlled Drug Release
Current Topics in Medicinal Chemistry Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design Antiangiogenic Therapy
Current Pharmaceutical Design Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
Current Cancer Drug Targets The Effectiveness of Nanoparticles on Gene Therapy for Glioblastoma Cells Apoptosis: A Systematic Review
Current Gene Therapy Resistance to Peloruside A and Laulimalide: Functional Significance of Acquired βI-tubulin Mutations at Sites Important for Drug-Tubulin Binding
Current Cancer Drug Targets Dendritic Cell Immunotherapy for Melanoma
Reviews on Recent Clinical Trials Novel Beta-Lactam Antibiotics Derivatives: Their New Applications as Gene Reporters, Antitumor Prodrugs and Enzyme Inhibitors
Mini-Reviews in Medicinal Chemistry Small Molecule Integrin Antagonists in Cancer Therapy
Mini-Reviews in Medicinal Chemistry Adenovirus As An Integrating Vector
Current Gene Therapy Exosomal MicroRNAs in Tumoral U87 MG Versus Normal Astrocyte Cells
MicroRNA Potential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer
Current Cancer Drug Targets